Cosmic Management’s BioAge Labs BIOA Stock Holding History

Cosmic Management’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3M	Hold	501,833	–	–	3.22%	5
2026 Q1	$8.78M	Hold	501,833	–	–	3.84%	4
2025 Q4	$6.64M	Buy	+501,833	New	+$4.45M	2.05%	4

Other funds holding BIOA

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Cosmic Management's BIOA Position: Q2 2026 in Review

Cosmic Management held its BioAge Labs (BIOA) position steady in Q2 2026 at 501,833 shares worth $12.3M. The position accounts for 3.22% of the portfolio, ranked #5.

Cosmic Management first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

Cosmic Management held 501,833 shares of BioAge Labs worth $12.3M as of Q2 2026.
Cosmic Management left its BioAge Labs share count unchanged in Q2 2026.
BioAge Labs made up 3.22% of Cosmic Management's portfolio in Q2 2026, its #5 holding.
Cosmic Management first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Cosmic Management's 13F filing for Q2 2026, filed 13 Aug 2026.